ARCHIVES

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 7 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCAB Approves New Nutrition Task Force With Earmarked Funds

May 28, 1982

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

NCI Programs: Functional Imaging Centers Grant Program Approved By Advisors

December 11, 1998

New Mexico Program Covers Entire State

January 21, 1977

Tim Lee Carter Named Chairman Of NCAB; Five Others Appointed

June 11, 1982

Clinical Trials Approved By NCI CTEP During July

August 30, 2002